AstraZeneca Says It Will Withdraw COVID-19 Vaccine Globally as Demand Dips
![](https://japannews.yomiuri.co.jp/wp-content/uploads/2024/05/2022-01-16T000000Z_118808965_RC2H0S95QVU0_RTRMADP_3_HEALTH-CORONAVIRUS-VACCINE.jpg)
A vial labelled “AstraZeneca COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.
13:09 JST, May 8, 2024
AstraZeneca AZN.Lsaid on Tuesday it had initiatedthe worldwide withdrawal ofits COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe.
“As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm’s application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
"News Services" POPULAR ARTICLE
-
FBI Identifies Thomas Matthew Crooks as ‘Subject Involved’ in Trump Rally Shooting
-
Donald Trump Whisked off Stage in Pennsylvania after Apparent Gunshots Rang Through the Crowd
-
Japanese Executive among 11 Arrested in Myanmar for Inflating Rice Prices
-
Japan’s Nikkei Reclaims 40,000 Level on Weak Yen, Foreign Buying (UPDATE 1)
-
U.S. President Joe Biden Drops Out of the 2024 Race after Disastrous Debate Inflamed Age Concerns
JN ACCESS RANKING